Goldman Sachs’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $620K | Sell |
|
|||||
|
2025
Q1 | $213K | Sell |
|
|||||
|
2024
Q4 | $700K | Sell |
|
|||||
|
2024
Q3 | $2.34M | Buy |
|
|||||
|
2024
Q2 | $1.61M | Sell |
|
|||||
|
2024
Q1 | $3.14M | Buy |
|
|||||
|
2023
Q4 | $1.55M | Buy |
|
|||||
|
2023
Q3 | $226K | Buy |
|
|||||
|
2023
Q2 | $192K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $12.5K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $60K | Sell |
|
|||||
|
2022
Q1 | $54K | Buy |
|
|||||
|
2021
Q4 | $90K | Sell |
|
|||||
|
2021
Q3 | $192K | Sell |
|
|||||
|
2021
Q2 | $329K | Sell |
|
|||||
|
2021
Q1 | $471K | Buy |
|
|||||
|
2020
Q4 | $430K | Buy |
|
|||||
|
2020
Q3 | $360K | Buy |
|